Blog Post

Five Key Takeaways from FDA’s Transparency of AI/Ml-Enabled Medical Devices Virtual Workshop

MoFo Life Sciences

26 Oct 2021

On October 14, 2021, the Food and Drug Administration (FDA) held a virtual public workshop on transparency surrounding Artificial Intelligence/Machine Learning (AI/ML) enabled medical devices.  The workshop focused on the role of transparency in enhancing the safe and effective use of AI/ML technology in the medical device space, with an emphasis on information-sharing methods for patients, caregivers, and providers.

Read the blog post.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.